Overview Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx Status: Completed Trial end date: 2007-12-01 Target enrollment: Participant gender: Summary To test the ability of new imaging techniques to monitor and predict response of pancreatic cancer to radiation and/or chemotherapy. Phase: N/A Details Lead Sponsor: Stanford University